To hear about similar clinical trials, please enter your email below
Trial Title:
Regional Database for Collecting Clinical-biological and Imaging Data "Secondary Bone Oncology and Bone Localizations of Hematologic Diseases"
NCT ID:
NCT05495802
Condition:
Bone Metastases
Conditions: Official terms:
Neoplasm Metastasis
Hematologic Diseases
Conditions: Keywords:
bone localisations of haematological diseases
Cancer
bone metastasis
haematological diseases
quality of life
epidemiological data
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Improving the effectiveness of cancer treatments makes it possible to lengthen patient
survival. It is therefore important to ensure that the quality of life is also maintained
by reducing pain and handicap.
Some cancers tend to spread to the bone. The bone locations of cancer can weaken the bone
and lead to complications such as fractures, pain, or compression of neurological
structures.
To avoid such complications, weekly multidisciplinary meetings (MM) bring together
specialists (oncologists, rheumatologists, cancer surgeons, radiologists,
radiotherapists, etc.) to discuss the files of patients with bone lesions from cancer.
They offer specific treatments adapted to each patient to treat or reduce the risk of
complications. The OOSLOH study aims to collect clinical, biological, and imaging data
from patients for whom a discussion took place in bone dedicated MM. Based on these data,
epidemiological studies could be carried out to better understand the clinical factors
leading cancer to colonize bone. But also to determine the factors making it possible to
prevent or better treat bone complications and improve the quality of life of patients.
This study does not require any examinations or additional visits to the patient
Criteria for eligibility:
Study pop:
Patients whose file is presented in MM OOSLOH for a diagnostic, therapeutic or follow-up
question of a malignant bone lesion
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient aged 18 or over,
- Patient whose file is presented to the OOSLOH MM and who has not objected to the use
of his non-nominative clinical, biological and imaging data
- Social insured patient
Exclusion Criteria:
- Patient who died before presentation to OOSLOH MM,
- Minor patient,
- Patient objecting to the use of their data for research purposes,
- Patient unable to express his right to object to his participation in the study.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
December 2022
Completion date:
December 2032
Lead sponsor:
Agency:
University Hospital, Lille
Agency class:
Other
Collaborator:
Agency:
Lille University Hospital Emergence Fund
Agency class:
Other
Source:
University Hospital, Lille
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05495802